Why the study?
Does levosimendan prevent hypertension-induced cardiac remodeling and cardiomyocyte apoptosis in a rat model of heart failure?
Population
6-week-old salt-sensitive Dahl/Rapp rats on high salt diet (NaCl 7%)
Comparison
Levosimendan for 7 weeks vs Untreated Dahl/Rapp rats on high salt diet
Design
Preclinical
Follow-up
7 weeks
Authors
Loading...
May inform preclinical testing in hypertensive cardiomyopathy; leaves open clinical translation from this rat model.
Does levosimendan prevent hypertension-induced cardiac remodeling and cardiomyocyte apoptosis in a rat model of heart failure?
In a rat model of hypertension-induced heart failure, levosimendan improved survival and ameliorated cardiac remodeling and cardiomyocyte apoptosis.
Louhelainen et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: